Posted by Michael Wonder on 13 Jul 2018
FDA budget matters: investing in advanced domestic manufacturing
13 July 2018 - There’s new technology that can improve drug quality, address shortages of medicines, lower drug costs, and bring pharmaceutical manufacturing back to the United States.
At the FDA, we’re focused on propelling these innovations, collectively referred to as advanced manufacturing.
Advanced manufacturing, which includes various technologies, such as continuous manufacturing and 3D printing, holds great promise for improving the American market for drugs and biologicals.
